HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 100 filers reported holding HARVARD BIOSCIENCE INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $377,390 | +88.6% | 87,765 | +140.8% | 0.03% | +82.4% |
| Q2 2023 | $200,105 | +132.7% | 36,449 | +198.4% | 0.02% | +240.0% |
| Q4 2021 | $86,000 | -80.3% | 12,216 | -80.5% | 0.01% | -79.2% |
| Q3 2021 | $437,000 | -24.4% | 62,657 | -9.7% | 0.02% | -22.6% |
| Q2 2021 | $578,000 | +51.3% | 69,420 | -0.9% | 0.03% | +40.9% |
| Q1 2021 | $382,000 | +29.5% | 70,038 | +1.9% | 0.02% | +4.8% |
| Q4 2020 | $295,000 | -3.9% | 68,710 | -32.6% | 0.02% | +110.0% |
| Q3 2020 | $307,000 | -24.6% | 101,936 | -22.4% | 0.01% | -9.1% |
| Q2 2020 | $407,000 | +324.0% | 131,418 | +202.3% | 0.01% | +266.7% |
| Q1 2020 | $96,000 | -33.8% | 43,475 | -8.3% | 0.00% | +50.0% |
| Q4 2019 | $145,000 | +1.4% | 47,434 | +2.3% | 0.00% | 0.0% |
| Q3 2019 | $143,000 | – | 46,380 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Harvey Partners, LLC | 1,020,036 | $7,120,000 | 5.32% |
| Portolan Capital Management | 2,358,010 | $16,459,000 | 1.20% |
| Acuitas Investments, LLC | 375,836 | $2,623,000 | 1.14% |
| Parkman Healthcare Partners LLC | 475,367 | $3,318,000 | 0.84% |
| Adirondack Research & Management Inc. | 90,020 | $628,000 | 0.76% |
| Archon Capital Management LLC | 736,236 | $5,139,000 | 0.73% |
| BARD ASSOCIATES INC | 294,697 | $2,057,000 | 0.70% |
| PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 1,621,775 | $11,320,000 | 0.65% |
| GLOBEFLEX CAPITAL L P | 268,466 | $1,874,000 | 0.41% |
| Monarch Partners Asset Management LLC | 330,083 | $2,304,000 | 0.34% |